Month: September 2019

Macrophage Pharma Appoints Dr Søren Bregenholt as Chief Executive Officer

Strategic and operational leadership expanded for progressing broad pipeline  03 September 2019, Windsor, UK: Macrophage Pharma Limited (‘MPL’), a company focused on the discovery and development of next-generation immunomodulatory small molecules inducing transcriptional reprofiling of macrophages to combat cancer and other diseases, announced today that it has appointed Dr Soren Bregenholt as Chief Executive … Continue reading “Macrophage Pharma Appoints Dr Søren Bregenholt as Chief Executive Officer”